(Dexamethasone/Moxifloxacin)
Dexamethasone & Moxifloxacin, now available from our FDA-Registered Outsourcing Facility.
Click here to download the product insert for this formulation.
| Classification | Injectable |
|---|---|
| Strength (Concentration) common dose* | 1mg/5mg/mL |
| Size (Volume) | Single Use Vial |
*For professional use only. ImprimisRx® Pharmacy specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.
Potential Ingredient Risks
Storage: Store at Room Temperature, 20°C to 25°C (68°F to 77°F)
Auxiliary Labeling: Store upright in original bottle. For professional use only.
Dexamethasone Sodium Phosphate
Possible Indications: Postoperative Inflammation, Allergic Conjunctivitis, Inflammation of Anterior Segment of Eye, Keratitis, Optic Neuritis, Iritis, Sympathetic Ophthalmia
Possible Adverse Effects: Conjunctival Irritation, Burning and Stinging Sensation, Fever, Eye Irritation and Infection, Airway Obstruction, Anaphylaxis, Angioedema, Circulatory Shock, Blindness, Post-Injection Flare, Would Healing Suppression, Corneal Perforation, Headache, Subcapsular Posterior Cataract, Ocular Hypertension, Optic Nerve Damage, Visual Field Defect
Potential Contraindications/Precautions:
Infants and patients less than 12 years of age, Lactation, Pregnancy
Moxifloxacin HCl
Possible Indications: Bacterial Conjunctivitis
Possible Adverse Effects: Conjunctival Irritation, Fever, Eye Irritation, Airway Obstruction, Anaphylaxis, Angioedema, Circulatory Shock, Dyspnea, Facial Edema, Fungal Superinfection, Laryngeal Edema, Loss of Consciousness, Pharyngeal Edema, Pruritus, Superinfection, Urticaria, Pigment Dispersion Syndrome
Potential Contraindications/Precautions: Infants, Lactation, Pregnancy